Recent

% | $
Quotes you view appear here for quick access.

MannKind Corp. Message Board

mnkdholderof 39 posts  |  Last Activity: Aug 24, 2015 5:22 PM Member since: Jul 3, 2013
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • mnkdholderof by mnkdholderof Aug 24, 2015 5:22 PM Flag

    That renewal rate is high
    That more diabetics are starting to use Afrezza each week
    Insurance coverage will keep improving as noted in CC's (this will be key in driving up #'s of new users)
    Announcement of worldwide rollout in September-October (just weeks away)

  • mnkdholderof by mnkdholderof Aug 23, 2015 9:09 PM Flag

    Wow that is a really bold statement from the Fool.

    I find it hard to believe that this is a factual statement, but then what do I know.

    Hmmmm

    But lets see, Yahoo lets all the bashing articles come up as NEWS headlines from SA, Street, Motly Fool.

    Hmmm... do you think there is something going on with that....

  • mnkdholderof by mnkdholderof Aug 19, 2015 11:14 PM Flag

    Pfizer tried to market Exubera on the assumption that diabetics didn't care for the inconvenience of needles. It was right, but only to a point. The Exubera delivery device was about the diameter of a toilet paper tube and twice as long. It was far more conspicuous to use in public than a needle.

    Few people look twice at asthmatics using their inhalers, soon diabetics will enjoy the same convenience. MannKind's inconspicuous inhalers are tiny. A diabetic could administer a dose at a restaurant table without anybody noticing.

    The few patients that did use Exubera, quickly went back to injections because administering the proper dosage was horribly complicated. Afrezza addresses this problem by making the dosage much simpler.

    All Afrezza insulin cartridges contain a uniform amount of insulin -- unlike Exubera -- adjusting the dosage is simple arithmetic.

  • Sanofi and MannKind Announce Afrezza®, the Only Inhaled Insulin, Now Available in the U.S.
    Paris and Valencia, Calif. – February 3, 2015 – Sanofi and MannKind Corporation announced today that Afrezza® (insulin human) Inhalation Powder, the only inhaled insulin, is now available by prescription in U.S. retail pharmacies nationwide. Afrezza is approved by the U.S. Food and Drug Administration to control high blood sugar in adults with type 1 and type 2 diabetes.

  • What you are referring to, in investment parlance, is a "short squeeze." When a number of short sellers all try to "cover" their short at the same time, that does indeed drive the stock up.

    Our approach when shorting is therefore to avoid in general stocks that already have a fairly hefty amount of existing short sales. We try to set ourselves up so we'll never get squeezed.

    I'll point out that short squeezes can be the result of better than expected earnings or some other fundamental aspects of a company's operation. They can also be the result of direct manipulation. That is, profit-seeking individuals with large amounts of cash at their disposal can look on a large short position in a stock as an invitation to start buying, driving up the share prices, thus forcing short-sellers to cover. This in turn drives up the price, and before you know it, the share price has soared!

  • mnkdholderof by mnkdholderof Aug 19, 2015 8:05 PM Flag

    Who puts a bid in for 75,000 shares at 3.97 in late AHs... not retail that is for sure... the games the boys play

  • Reply to

    Time out

    by mnkdholderof Aug 13, 2015 10:05 PM
    mnkdholderof mnkdholderof Aug 13, 2015 10:40 PM Flag

    Just saying that all the thousands of messages on this board mean very little. SALES of Afrezza will come but it will TAKE TIME. Everybody is... I want it NOW. Flash forward a year from now and the current state will be flat out funny. LONG TERM INVSTMENT!

  • mnkdholderof by mnkdholderof Aug 13, 2015 10:05 PM Flag

    Apparently very few listen to CC's and what is really going on. It takes time to get the tier Insurance thing worked out so it is affordable to all. THIS WILL HAPPEN - IT TAKES 6-8 MONTHS.

    In the near term it will be a great thing when they announce worldwide rollout. Not that far off.

  • Reply to

    A Few Thoughts..

    by itellthefuture777 Jul 30, 2015 9:45 PM
    mnkdholderof mnkdholderof Jul 30, 2015 10:00 PM Flag

    I agree and good job on a sensible post. This will take some time to get over the initial hurdles. It will become a very nice fast acting mealtime insulin that is as easy as the millions of asthma people that take a puff on an inhaler to treat their condition.

    90% of the posts on this board are all I WANT IT NOW. lol

    Just think of the numbers in a few years as it is worldwide.

    Great for diabetics!

  • mnkdholderof by mnkdholderof Jul 29, 2015 9:43 PM Flag

    Remember that old Doris Day song...

    When I was just a little girl
    I asked my mother
    What will I be
    Will I be pretty
    Will I be rich
    Here's what she said to me

    Que sera, sera
    Whatever will be, will be
    The future's not ours to see
    Que sera, sera
    What will be, will be

    When I grew up and fell in love
    I asked my sweetheart
    What lies ahead
    Will we have rainbows
    Day after day
    Here's what my sweetheart said

    Que sera, sera
    Whatever will be, will be
    The future's not ours to see
    Que sera, sera
    What will be, will be

    Now I have Children of my own
    They ask their mother
    What will I be
    Will I be handsome
    Will I be rich
    I tell them tenderly

    Que sera, sera
    Whatever will be, will be
    The future's not ours to see
    Que sera, sera
    What will be, will be
    Que Sera, Sera

    SO WHAT IT ALL COMES DOWN TO IS...

    Afrezza becomes a significant worldwide treatment for Diabetes or it does not.
    (It will take some time but I believe it will)

    Que sera, sera

  • mnkdholderof by mnkdholderof Jul 25, 2015 7:51 PM Flag

    Why spend a lot on advertising when they need to work out the kinks on lung test issue, label, insurance tier etc. As these are resolved and it becomes much easier to get on Afrezza and it being covered for all at a competitive price.... Then maybe spend some good chunks of change on advertising. It will all work out over time.

    Me I am exited when they announce the rollout into other regions of the world!! Coming soon...

    What most need to understand is Sanofi is picking up the biggest share of costs now and MannKind will eventually be bringing in the 25% (effectively) royalty to fund TS down the road.

  • Reply to

    Other regions

    by mnkdholderof Jul 20, 2015 4:54 PM
    mnkdholderof mnkdholderof Jul 20, 2015 7:09 PM Flag

    We know from Management that they were meeting in 1st part of July with Sanofi to discuss the rollout to other regions per CC (if you listened). So I expect this announcement to come soon. Ridiculous?

  • mnkdholderof by mnkdholderof Jul 20, 2015 4:54 PM Flag

    I would not say it is a leak but lets just say the announcement from Sanofi on what regions Afrezza will go into next is coming soon. MM knows this and will drive price down as much as they can before the next big spike from this PR.

  • mnkdholderof by mnkdholderof Jul 16, 2015 8:06 PM Flag

    Cough Approximately 27% of patients treated with AFREZZA reported cough, compared to approximately 5.2% of patients treated with comparator. In clinical trials, cough was the most common reason for discontinuation of AFREZZA therapy

  • Reply to

    Will happen very quickly

    by mnkdholderof Jul 7, 2015 8:10 PM
    mnkdholderof mnkdholderof Jul 14, 2015 6:01 PM Flag

    How often does a CFO use the word 'quickly' when he knows his statement is on a CC for all to hear. They are normally very cautious on a statement like that. Bumping this back up as it is important to realize that the balance sheet will take care of itself going forward. $ NO MORE SHARES WILL BE ISSUED!

  • We know Mankind is meeting with Sanofi in July per CC to discuss worldwide rollout. Soooo... what region or regions will be announced for Afrezza? soon me thinks

  • Reply to

    Ouch

    by mnkdholderof Jul 7, 2015 10:09 PM
    mnkdholderof mnkdholderof Jul 7, 2015 10:16 PM Flag

    . About 45 percent of China’s listed companies are suspended, leading traders to sell what they can

    WOW that is scarey.

  • mnkdholderof by mnkdholderof Jul 7, 2015 10:09 PM Flag

    HANG SENG INDEX down almost 5%

    Could be a rough day tomorrow

  • Reply to

    Will happen very quickly

    by mnkdholderof Jul 7, 2015 8:10 PM
    mnkdholderof mnkdholderof Jul 7, 2015 9:27 PM Flag

    I wonder if the CFO of Mankind would like to respond to your brilliant post. Most likely not, he is too busy these days.

  • mnkdholderof by mnkdholderof Jul 7, 2015 8:10 PM Flag

    "It will happen very quickly"

    This is what Matthew J. Pfeffer CFO stated in regards to profitability.

    From JMP Securities Life Sciences Conference a few weeks ago, 26 minute mark.

    Now he could of said next year or in a couple years but what did he say... 'quickly'

    So do you go with all the soft bashing articles, all the shorts, or go with the guy in charge of the books!

MNKD
3.71-0.08(-2.11%)Sep 1 4:00 PMEDT